NOUVEAUX PEPTIDES ET COMBINAISON DE PEPTIDES À UTILISER EN IMMUNOTHÉRAPIE CONTRE LE CANCER DE L'OVAIRE ET D'AUTRES CANCERS

• 收藏
• 分享

专利权人:

immatics biotechnologies GmbH

发明人:

申请号：

EP20170129.9

公开号：

EP3712165A2

申请日:

2016.06.29

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

Provided is a peptide of up to 30 amino acids comprising the amino acid sequence of SEQ ID NO: 3, SEQ ID NO: 1 or SEQ ID NO: 2, or one of SEQ ID NO: 4 to SEQ ID NO: 10 or SEQ ID NO: 12 to SEQ ID NO: 640. Provided are inter alia also a nucleic acid encoding such peptide, a host cell comprising the same, a T-cell receptor reactive with such peptide and an activated T lymphocyte recognizing a cell which presents such peptide. Provided is also the use of any of the above in cancer treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/